Interaction of soy isoflavones and their main metabolites with hOATP2B1 transporter (vol 391, pg 1063, 2018)

被引:1
|
作者
Navratilova, Lucie [1 ]
Applova, Lenka [1 ]
Horky, Pavel [2 ]
Mladenka, Premysl [1 ]
Pavek, Petr [1 ]
Trejtnar, Frantisek [1 ]
机构
[1] Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Pharmacol & Toxicol, Hradec Kralove, Czech Republic
[2] Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Organ & Bioorgan Chem, Hradec Kralove, Czech Republic
关键词
Drug transporter; Flavonoids; OATP; SLCO; Soy isoflavones;
D O I
10.1007/s00210-018-1541-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Membrane organic anion-transporting polypeptides (OATPs) are responsible for the drug transmembrane transport within the human body. The function of OATP2B1 transporter can be inhibited by various natural compounds. Despite increased research interest in soya as a part of human diet, the effect of its active components to interact with hOATP2B1 has not been elucidated in a complex extent. This in vitro study examined the inhibitory effect of main soy isoflavones (daidzin, daidzein, genistin, genistein, glycitin, glycitein, biochanin A, formononetin) and their metabolites formed in vivo (S-equol, O-desmethylangolensin) towards human OATP2B1 transporter. MDCKII cells overexpressing hOATP2B1 were employed to determine quantitative inhibitory parameters of the tested compounds and to analyze mechanism/s of the inhibitory interaction. The study showed that aglycones of soy isoflavones and the main biologically active metabolite S-equol were able to significantly inhibit hOATP2B1-mediated transport. The K-i values for most of aglycones range from 1 to 20 mu M. In contrast, glucosides did not exhibit significant inhibitory effect. The kinetic analysis did not indicate a uniform type of inhibition towards the hOATP2B1 although predominant mechanism of inhibition seemed to be competitive. These findings may suggest that tested soy isoflavones and their metabolites might affect transport of xenobiotics including drugs across tissue barriers via hOATP2B1.
引用
收藏
页码:1073 / 1073
页数:1
相关论文
共 30 条
  • [1] Interaction of soy isoflavones and their main metabolites with hOATP2B1 transporter
    Lucie Navrátilová
    Lenka Applová
    Pavel Horký
    Přemysl Mladěnka
    Petr Pávek
    František Trejtnar
    [J]. Naunyn-Schmiedeberg's Archives of Pharmacology, 2018, 391 : 1063 - 1071
  • [2] PGA2-induced expression of HO-1 is mediated by transcriptional upregulation of Nrf2 (vol 14, pg 391, 2018)
    Lee, Sang-sun
    Choe, Yun-Jeong
    Lee, Hyein
    Lee, Sun-Young
    Kim, Ho-Shik
    [J]. MOLECULAR & CELLULAR TOXICOLOGY, 2019, 15 (02) : 231 - 232
  • [3] RETRACTED: Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo (Retracted article. See vol. 78, pg. 6028, 2018)
    Raffoul, Julian J.
    Banerjee, Sanjeev
    Singh-Gupta, Vinita
    Knoll, Zvi E.
    Fite, Alemu
    Zhang, Hao
    Abrams, Judith
    Sarkar, Fazlul H.
    Hillman, Gilda G.
    [J]. CANCER RESEARCH, 2007, 67 (05) : 2141 - 2149
  • [4] Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy (vol 132, pg 694, 2018)
    Porpaczy, E.
    Tripolt, S.
    Hoelbl-Kovacic, A.
    [J]. BLOOD, 2019, 133 (07) : 768 - 768
  • [5] Experimental study of the mean structure and quasi-conical scaling of a swept-compression-ramp interaction at Mach 2 (vol 841, pg 1, 2018)
    Vanstone
    Musta, Mastafa Nail
    [J]. JOURNAL OF FLUID MECHANICS, 2018, 843 : 898 - 898
  • [6] Identification of Exo1-Msh2 interaction motifs in DNA mismatch repair and new Msh2-binding partners (vol 25, pg 650, 2018)
    Goellner, Eva M.
    Putnam, Christopher D.
    Graham, William J.
    Rahal, Christine M.
    Li, Bin-Zhong
    Kolodner, Richard D.
    [J]. NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2019, 26 (12) : 1184 - 1184
  • [7] CLONING OF A BCL-2 HOMOLOG BY INTERACTION WITH ADENOVIRUS E1B 19K (VOL 374, PG 731, 1995)
    FARROW, SN
    WHITE, JHM
    MARTINOU, I
    RAVEN, T
    PUN, KT
    GRINHAM, CJ
    MARTINOU, JC
    BROWN, R
    [J]. NATURE, 1995, 375 (6530) : 431 - 431
  • [8] Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies (vol 391, pg 839, 2018)
    Llibre, J. M.
    Hung, C-C
    Brinson, C.
    [J]. LANCET, 2018, 391 (10138): : 2416 - 2416
  • [9] The Effect of SH2B1 Variants on Expression of Leptin- and Insulin-Induced Pathways in Murine Hypothalamus (vol 11, pg 93, 2018)
    Giuranna, Johanna
    Volckmar, Anna-Lena
    Heinen, Anna
    Peters, Triinu
    Schmidt, Borge
    Spieker, Anne
    Straub, Helena
    Grallert, Harald
    Mueller, Timo D.
    Antel, Jochen
    Haussmann, Ute
    Klafki, Hans
    Rui, Liangyou
    Hebebrand, Johannes
    Hinney, Anke
    [J]. OBESITY FACTS, 2018, 11 (03) : 176 - 180
  • [10] LncRNA MALAT1 regulates sepsis-induced cardiac inflammation and dysfunction via interaction with miR-125b and p38 MAPK/NFκB (vol 55, pg 69, 2018)
    Chen, Hu
    Wang, Xiaoyun
    Yan, Xuetao
    Cheng, Xiaoli
    He, Xianghu
    Zheng, Wenzhong
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 97